GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 420 filers reported holding GUARDANT HEALTH INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,274,000 | +0.4% | 170,198 | +51.7% | 0.80% | +13.0% |
| Q4 2021 | $11,224,000 | -4.8% | 112,213 | +18.9% | 0.71% | -17.5% |
| Q3 2021 | $11,796,000 | -25.3% | 94,363 | -25.8% | 0.86% | -13.1% |
| Q2 2021 | $15,800,000 | -33.0% | 127,223 | -17.7% | 0.99% | -39.7% |
| Q1 2021 | $23,585,000 | +20.4% | 154,507 | +1.6% | 1.64% | +8.6% |
| Q4 2020 | $19,596,000 | +26.9% | 152,048 | +10.1% | 1.51% | -9.3% |
| Q3 2020 | $15,437,000 | +1090.2% | 138,100 | +763.8% | 1.67% | +534.6% |
| Q2 2020 | $1,297,000 | -56.3% | 15,987 | -62.5% | 0.26% | -54.4% |
| Q1 2020 | $2,965,000 | -10.2% | 42,596 | +0.8% | 0.58% | +69.7% |
| Q4 2019 | $3,300,000 | -44.8% | 42,238 | -54.9% | 0.34% | -32.4% |
| Q3 2019 | $5,979,000 | -26.3% | 93,672 | -0.3% | 0.50% | -32.4% |
| Q2 2019 | $8,108,000 | – | 93,916 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |